TY - JOUR
T1 - Measurement of Eicosanoids in Cancer Tissues
AU - Wang, Dingzhi
AU - DuBois, Raymond N.
PY - 2007
Y1 - 2007
N2 - Eicosanoids derived from arachidonic acid through cyclooxygenase (COX), lipoxygenase (LOX), and P450 pathways include prostanoids, hydroxyeicosatetraenoic acids (HETEs), leukotrienes (LTs), and epoxyeicosatrienoic acids (EETs). These bioactive lipids play an important role in regulating cell proliferation, apoptosis, tissue repair, blood clotting, blood vessel permeability, inflammation, and immune cell behavior. Moreover, some of these eicosanoids also modulate inflammation and tumor growth in cancer tissues, and may serve as biomarkers for monitoring colorectal cancer progression or as an intermediate marker for the pharmacologic activity of chemopreventive agents. Development of sensitive, rapid, and specific methods for determining eicosanoid levels accurately will facilitate an understanding of the biologic functions of these lipid mediators and will broaden our insight of the importance of these bioactive lipids in vivo. However, quantitative determination of eicosanoids in biological samples has presented a problem to many investigators. It is necessary to understand the advantages and limitations of each method for quantitative analysis of specific eicosanoids in various types of biological samples. Here we evaluate the methodology of the measurement of eicosanoids in biological samples.
AB - Eicosanoids derived from arachidonic acid through cyclooxygenase (COX), lipoxygenase (LOX), and P450 pathways include prostanoids, hydroxyeicosatetraenoic acids (HETEs), leukotrienes (LTs), and epoxyeicosatrienoic acids (EETs). These bioactive lipids play an important role in regulating cell proliferation, apoptosis, tissue repair, blood clotting, blood vessel permeability, inflammation, and immune cell behavior. Moreover, some of these eicosanoids also modulate inflammation and tumor growth in cancer tissues, and may serve as biomarkers for monitoring colorectal cancer progression or as an intermediate marker for the pharmacologic activity of chemopreventive agents. Development of sensitive, rapid, and specific methods for determining eicosanoid levels accurately will facilitate an understanding of the biologic functions of these lipid mediators and will broaden our insight of the importance of these bioactive lipids in vivo. However, quantitative determination of eicosanoids in biological samples has presented a problem to many investigators. It is necessary to understand the advantages and limitations of each method for quantitative analysis of specific eicosanoids in various types of biological samples. Here we evaluate the methodology of the measurement of eicosanoids in biological samples.
UR - http://www.scopus.com/inward/record.url?scp=38449095968&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=38449095968&partnerID=8YFLogxK
U2 - 10.1016/S0076-6879(07)33002-4
DO - 10.1016/S0076-6879(07)33002-4
M3 - Article
C2 - 17954227
AN - SCOPUS:38449095968
SN - 0076-6879
VL - 433
SP - 27
EP - 50
JO - Methods in Enzymology
JF - Methods in Enzymology
ER -